Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cannabis Pharmaceuticals Market Size, Value And Growth Trends Through 2030
The market for pharmaceutical cannabis has seen significant expansion recently. Projections indicate a rise from $9.43 billion in 2025 to $14.74 billion in 2026, reflecting a compound annual growth rate (CAGR) of 56.3%. This upward trend during the review period has been influenced by several factors, including a growing awareness of the medicinal advantages offered by cannabinoids, a broader adoption of prescriptions for medical cannabis, the introduction of initial pharmaceutical products derived from cannabis, an increase in pain management initiatives within hospital settings, and the attainment of regulatory endorsements for specific cannabis-based medications.
The cannabis pharmaceuticals sector is poised for significant expansion in the coming years, projecting a market value of $85.68 billion by 2030, driven by a compound annual growth rate of 55.3%. This projected surge is fueled by several key factors, including amplified investment in clinical trials for cannabis-based drugs, a growing need for consistent cannabinoid formulations, the broadening application of these pharmaceuticals in treating neurological conditions and cancer, increasing integration of cannabis medicines within hospital settings, and a trend toward greater regulatory consistency across different markets. During this forecast period, notable developments are expected to encompass the advancement of cannabis medications intended for prescription use, a heightened emphasis on empirical validation through clinical studies, expanded utilization for neurological ailments and pain management, the growth of well-defined pharmaceutical development pathways for cannabis products, and a stronger focus on achieving precise dosages.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20723&type=smp
Cannabis Pharmaceuticals Market Demand Drivers: What Is Fueling Industry Growth?
The increasing prevalence of epilepsy is anticipated to be a key growth factor for the cannabis pharmaceuticals sector. Epilepsy, a neurological condition defined by recurring, unprovoked seizures stemming from aberrant brain electrical activity, is experiencing a surge in diagnoses due to improved detection methods, heightened public awareness, and more comprehensive reporting, in addition to possible contributions from environmental, genetic, and lifestyle factors. Cannabinoid-based pharmaceuticals are demonstrating promise in epilepsy management by leveraging compounds such as CBD to mitigate seizure frequency and intensity, particularly for individuals unresponsive to conventional anti-seizure medications. Illustrating this trend, figures released by the World Health Organization in February 2024 indicated that approximately 50 million individuals globally were living with epilepsy. Consequently, this upward trend in epilepsy cases is fueling the expansion of the cannabis pharmaceuticals market.
#Cannabis Pharmaceuticals Market Segment Landscape And Growth Potential
The cannabis pharmaceuticals market covered in this report is segmented –
1) By Product Type: Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids
2) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries
Subsegments:
1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations
2) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists
Cannabis Pharmaceuticals Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading enterprises within the cannabis pharmaceuticals sector are prioritizing the creation of novel offerings, notably sophisticated medical cannabis preparations aimed at alleviating diverse health ailments and enhancing therapeutic results. These advanced medical cannabis formulations are defined as meticulously engineered cannabis derivatives tailored for medicinal application, featuring exact concentrations of cannabinoids such as THC and CBD. As an illustration, during April 2024, Canexis Pharma AG, a pharmaceutical entity headquartered in Switzerland, secured essential manufacturing and narcotics permits from Swissmedic, granting them the authority to manufacture high-quality medicinal active compounds sourced from CBD and THC, thereby enabling them to cater to the escalating need for medical cannabis both domestically and internationally, underscoring their adherence to rigorous regulatory frameworks and solidifying their capacity to contribute to the dynamic medical cannabis landscape.
Cannabis Pharmaceuticals Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the cannabis pharmaceuticals market are Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc.
Access The Complete Cannabis Pharmaceuticals Market Report:
https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report
Cannabis Pharmaceuticals Market Geographic Distribution And Regional Opportunities
North Americawas the largest region in the cannabis pharmaceuticals market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model